Effects of gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in artificial cycles: a meta-analysis

[1] Wu H(2021)Endometrial preparation for frozen-thawed embryo transfer cycles: a systematic review and network meta-analysis J Assist Reprod Genet 38 1913-1926

[2] Zhou P(2010)Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy Hum Reprod 25 642-653

[3] Lin X(2020)Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes Cochrane Database Syst Rev 10 CD006359-688

[4] Khan KN(2003)Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinases-1 messenger ribonucleic acid levels in human decidual stromal cells in vitro J Clin Endocrinol Metab 88 680-923

[5] Kitajima M(1998)Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation Fertil Steril 69 916-282

[6] Hiraki K(2000)VEGF, its receptors and the tie receptors in recurrent miscarriage Mol Hum Reprod 6 276-556

[7] Glujovsky D(2007)The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role? J Assist Reprod Genet 24 553-879

[8] Pesce R(2004)Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles Random Study Hum Reprod 19 874-471

[9] Sueldo C(1998)Molecular control of the implantation window Hum Reprod Update 4 465-245

[10] Chou CS(2014)Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials Cochrane Database Syst Rev 63 238-956

[1] Wu H(2021)Endometrial preparation for frozen-thawed embryo transfer cycles: a systematic review and network meta-analysis J Assist Reprod Genet 38 1913-1926

[2] Zhou P(2010)Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy Hum Reprod 25 642-653

[3] Lin X(2020)Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes Cochrane Database Syst Rev 10 CD006359-688

[4] Khan KN(2003)Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinases-1 messenger ribonucleic acid levels in human decidual stromal cells in vitro J Clin Endocrinol Metab 88 680-923

[5] Kitajima M(1998)Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation Fertil Steril 69 916-282

[6] Hiraki K(2000)VEGF, its receptors and the tie receptors in recurrent miscarriage Mol Hum Reprod 6 276-556

[7] Glujovsky D(2007)The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role? J Assist Reprod Genet 24 553-879

[8] Pesce R(2004)Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles Random Study Hum Reprod 19 874-471

[9] Sueldo C(1998)Molecular control of the implantation window Hum Reprod Update 4 465-245

[10] Chou CS(2014)Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials Cochrane Database Syst Rev 63 238-956